TR200100885T2 - 2-Metil-tieno-benzodiazepin formülasyonu - Google Patents

2-Metil-tieno-benzodiazepin formülasyonu

Info

Publication number
TR200100885T2
TR200100885T2 TR2001/00885T TR200100885T TR200100885T2 TR 200100885 T2 TR200100885 T2 TR 200100885T2 TR 2001/00885 T TR2001/00885 T TR 2001/00885T TR 200100885 T TR200100885 T TR 200100885T TR 200100885 T2 TR200100885 T2 TR 200100885T2
Authority
TR
Turkey
Prior art keywords
thieno
methyl
benzodiazepine formulation
formulation
benzodiazepine
Prior art date
Application number
TR2001/00885T
Other languages
English (en)
Inventor
Harry Ferguson Thomas
Arthur Bunnell Charles
Arnold Hendriksen Barry
Vicente Sanchez-Felix Manuel
Edward Tupper David
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200100885T2 publication Critical patent/TR200100885T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu bulus, olanzapinin farmasötik açidan kabul edilebilir bir yagli veya kolesterol mikro kürecik formülasyonunu saglar.Bulus ayrica,yeni olanzapin pamoat tuzlari veya bunlarin solvatlarini saglar.
TR2001/00885T 1998-09-30 1999-03-24 2-Metil-tieno-benzodiazepin formülasyonu TR200100885T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation

Publications (1)

Publication Number Publication Date
TR200100885T2 true TR200100885T2 (tr) 2001-08-21

Family

ID=26859927

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00885T TR200100885T2 (tr) 1998-09-30 1999-03-24 2-Metil-tieno-benzodiazepin formülasyonu

Country Status (28)

Country Link
EP (1) EP1119359B1 (tr)
JP (1) JP4551988B2 (tr)
CN (1) CN1146422C (tr)
AT (2) ATE359793T1 (tr)
AU (1) AU759751B2 (tr)
BR (1) BR9914156A (tr)
CA (1) CA2344873A1 (tr)
CZ (1) CZ302367B6 (tr)
DE (2) DE69935873T2 (tr)
DK (2) DK1119359T3 (tr)
EA (1) EA002580B1 (tr)
ES (2) ES2221376T3 (tr)
GE (1) GEP20094818B (tr)
HK (1) HK1041199B (tr)
HR (1) HRP20010238B1 (tr)
HU (1) HU227400B1 (tr)
ID (1) ID29574A (tr)
IL (2) IL141766A0 (tr)
MY (1) MY126476A (tr)
NO (1) NO328243B1 (tr)
NZ (1) NZ510208A (tr)
PL (1) PL196821B1 (tr)
PT (2) PT1468689E (tr)
SK (1) SK285944B6 (tr)
TR (1) TR200100885T2 (tr)
TW (1) TW577890B (tr)
UA (1) UA66872C2 (tr)
WO (1) WO2000018408A1 (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
DE60019461T2 (de) * 1999-12-28 2005-09-22 Cipla Ltd., Bombay Neue polymorphe formen von olanzapin
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
ES2289974T1 (es) * 2004-07-14 2008-02-16 Shasun Chemicals And Drugs Limited Metodo mejorado para producir la forma i de la olanzapina.
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
CN101106972A (zh) * 2004-11-16 2008-01-16 伊兰制药国际有限公司 注射用纳米微粒奥氮平制剂
SI1838716T1 (sl) * 2005-01-05 2011-10-28 Lilly Co Eli Olanzapin pamoat dihidrat
CZ2006697A3 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
JP5486690B2 (ja) * 2009-11-16 2014-05-07 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ メラノコルチン受容体リガンドの医薬組成物
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
EP2629775A4 (en) 2010-10-18 2014-06-11 Dainippon Sumitomo Pharma Co INJECTABLE FORMULATION WITH DELAYED RELEASE
US9604995B2 (en) 2013-02-13 2017-03-28 Neuland Laboratories Limited Process for the preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
WO2018172850A1 (en) * 2017-03-20 2018-09-27 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulaitons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095499A1 (en) * 1992-05-08 1993-11-09 Petrus J. M. Van Den Oetelaar Depot preparation
DE69327542T2 (de) * 1992-11-17 2000-07-06 Yoshitomi Pharmaceutical Industries, Ltd. Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
JP2001500878A (ja) * 1996-09-23 2001-01-23 イーライ・リリー・アンド・カンパニー オランザピン二水和物ｄ
US6169084B1 (en) * 1997-09-30 2001-01-02 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation

Also Published As

Publication number Publication date
NZ510208A (en) 2003-04-29
NO20011583L (no) 2001-03-28
CZ20011149A3 (cs) 2002-01-16
EP1119359A4 (en) 2001-12-19
DE69917663T2 (de) 2005-05-25
WO2000018408A1 (en) 2000-04-06
AU759751B2 (en) 2003-05-01
DK1119359T3 (da) 2004-08-16
CN1146422C (zh) 2004-04-21
IL141766A0 (en) 2002-03-10
CZ302367B6 (cs) 2011-04-13
SK4162001A3 (en) 2002-03-05
ES2285294T3 (es) 2007-11-16
ATE359793T1 (de) 2007-05-15
PL196821B1 (pl) 2008-02-29
HUP0103636A2 (hu) 2002-01-28
NO20011583D0 (no) 2001-03-28
PT1468689E (pt) 2007-07-09
HU227400B1 (en) 2011-05-30
JP2002525330A (ja) 2002-08-13
HK1041199B (en) 2005-03-18
JP4551988B2 (ja) 2010-09-29
DK1468689T3 (da) 2007-08-13
IL141766A (en) 2006-12-31
GEP20094818B (en) 2009-11-10
EP1119359B1 (en) 2004-05-26
MY126476A (en) 2006-10-31
HRP20010238A2 (en) 2002-04-30
TW577890B (en) 2004-03-01
EA002580B1 (ru) 2002-06-27
DE69917663D1 (de) 2004-07-01
UA66872C2 (uk) 2004-06-15
PL346981A1 (en) 2002-03-11
HRP20010238B1 (en) 2006-05-31
ES2221376T3 (es) 2004-12-16
HK1041199A1 (en) 2002-07-05
HUP0103636A3 (en) 2003-05-28
PT1119359E (pt) 2004-08-31
DE69935873T2 (de) 2008-01-10
CA2344873A1 (en) 2000-04-06
ID29574A (id) 2001-09-06
EP1119359A1 (en) 2001-08-01
SK285944B6 (sk) 2007-11-02
BR9914156A (pt) 2001-06-26
AU3362799A (en) 2000-04-17
DE69935873D1 (de) 2007-05-31
CN1320038A (zh) 2001-10-31
NO328243B1 (no) 2010-01-11
EA200100406A1 (ru) 2001-10-22
ATE267602T1 (de) 2004-06-15

Similar Documents

Publication Publication Date Title
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
TR200100885T2 (tr) 2-Metil-tieno-benzodiazepin formülasyonu
BR9903578B1 (pt) composiÇÕes de toner.
ES2180899T3 (es) Dihidrato d de olanzapina.
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
ATE275557T1 (de) 2-substituierte 4,5-diarylimidazole
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
NL1006065A1 (nl) Inlegkruisje voor stringslip.
BR9902084A (pt) Heterociclos.
ATE251457T1 (de) Substituierte 1,2,3,4-tetrahydro-2- dibenzofuranamine und 2- aminocyclohepta(b)benzofurane
DK1073447T3 (da) N1-modificerede glycopeptider
ES2166045T3 (es) Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos.
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
FI982378A0 (fi) Järjestely kohteen tutkimiseen
BR9908946B1 (pt) forração.
IT1311356B1 (it) Disposizione di macchine.
FI980635A0 (fi) Foerfarande foer maetning av halten av fasta aemnen och luftmaengden i loesningar
ECSP972052A (es) Quinoxalinadionas
FI974583A0 (fi) Avvattningsfoerfarande och -element i samband med en sellulosatorkmaskin el.dyl.
ECSP992901A (es) Formulacion de 2- metil -tieno benzodiazepina
ES1039318Y (es) Conjunto de sartenes.
FI973758A0 (fi) Flaking anordning foer traevirke, saerskilt foer rundvirke
IT1287349B1 (it) Pertica per il livellamento di superfici intonacate.
ECSP993288A (es) ACTIVADORES DE hPPARy y hPPARa
DZ2644A1 (fr) Triazolo-Ä3,4-aÜ-pyridazine substituées en 1,2,4.